InspireMD Inc (NSPR) FinancialsNSPRInspireMD Inc

InspireMD Inc (NSPR) generates its revenue primarily from CGuard, which accounts for 100.0% of total sales, equivalent to $1.76M. Understanding this concentration is critical for investors evaluating how NSPR navigates market cycles within the Medical Equipment, Supplies & Distribution industry.

Evaluating the bottom line, InspireMD Inc maintains a gross margin of -43.70%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -815.64%, while the net margin is -808.81%. These profitability ratios, combined with a Return on Equity (ROE) of -202.81%, provide a clear picture of how effectively NSPR converts its operational activities into shareholder value.

In the context of the broader market, NSPR competes directly with industry leaders such as PMI and ACH. With a market capitalization of $32.41M, it holds a leading position in the sector. When comparing efficiency, NSPR's gross margin of -43.70% stands against PMI's 20.85% and ACH's 38.22%. Such benchmarking helps identify whether InspireMD Inc is trading at a premium or discount relative to its financial performance.

InspireMD reported a revenue of $3.4 million for Q1 2026, reflecting a 120% increase year-over-year. However, it continues to face significant net income losses, with a net income of -$14,324,000 in Q2 2026.